Exercise News and Research

Latest Exercise News and Research

Statins for all over 55: Study

The latest research findings suggest that when assessing the risk of heart problems, offering statins or drugs that lower cholesterol to all over-55s had the same results as testing for cholesterol or blood pressure problems. The authors have also argued it would be simpler and more cost effective.

5 May 2011

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Pfizer Inc. announced that Revatio (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.

5 May 2011

Boston Business Journal honors Tufts Health Plan for Worksite Wellness program

Tufts Health Plan recently received the prestigious honor of being recognized for its Worksite Wellness initiatives by the Boston Business Journal. As a finalist in the Boston Business Journal's listing of "HEALTHIEST EMPLOYERS," the non profit company was recognized as an organization that is deeply committed to improving the health of its employees and its workplace.

5 May 2011

ZIOPHARM reports net loss of $39.0 million for first quarter 2011

ZIOPHARM Oncology, Inc, an oncology small molecule and synthetic biology drug development company, today reported its financial results for the three months ended March 31, 2011, and provided an update on the Company's activities in the first quarter.

5 May 2011

Columbia Laboratories net revenues increase 74% to $12.5 million

Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2011.

5 May 2011

AARP launches campaign to preserve health and retirement security of older Americans

With the national debate heating up on raising the debt ceiling, AARP announced a new campaign today to fight against proposals with arbitrary limits, caps or triggers that would result in harmful cuts to critical Social Security and Medicare benefits that millions of Americans have earned through a lifetime of hard work.

5 May 2011

Leukotriene antagonists can serve as effective alternative to conventional asthma treatment

A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia.

5 May 2011

Physical exercise generates nitric oxide intermediates critical for cardioprotection

Exercise both reduces the risk of a heart attack and protects the heart from injury if a heart attack does occur. For years, doctors have been trying to dissect how this second benefit of exercise works, with the aim of finding ways to protect the heart after a heart attack.

5 May 2011

Cardiac Dimensions initiates two CARILLON device trials in Functional Mitral Regurgitation

Cardiac Dimensions, Inc. announced today the initiation of two new clinical studies using the CARILLON Mitral Contour System, an investigational device for percutaneous treatment of Functional Mitral Regurgitation.

4 May 2011

New online tool can help evaluate and improve emergency communications

Leveraging Israel's experience in dealing with crises on a daily basis, Ben-Gurion University of the Negev researcher, Dr. Zvi Reich, has launched a new online tool to help and evaluate and improve crisis preparedness and emergency communications.

4 May 2011

Structured exercise training can reduce HbA1c levels in patients with diabetes

Implementing structured exercise training, including aerobic, resistance or both, was associated with a greater reduction in hemoglobin A1c levels for patients with diabetes compared to patients in the control group, and longer weekly exercise duration was also associated with a greater decrease in these levels, according to results of an analysis of previous studies, published in the May 4 issue of JAMA.

4 May 2011

AHF cautions against fast track FDA-approval for expanded use of Gilead’s Truvada

During its quarterly meeting over the weekend, The Board of Directors of the AIDS Healthcare Foundation (AHF) adopted a resolution cautioning Gilead Sciences against seeking fast track FDA-approval for the expanded use of its best selling AIDS treatment, Truvada, as a possible form of pre-exposure prophylaxis (PrEP) to prevent the transmission of HIV.

4 May 2011

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the presentation of new data from the completed 36-month FAME Study of ILUVIEN for the treatment of Diabetic Macular Edema at the 2011 ARVO Annual Meeting.

4 May 2011

Thoratec reports $99.5 million revenue for first quarter 2011

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that revenues from continuing operations in the first quarter of fiscal 2011 were $99.5 million versus revenues of $99.3 million in the same period a year ago.

4 May 2011

Exercise linked to improved lung status in children with cystic fibrosis

A small Johns Hopkins Children's Center study of children and teens with cystic fibrosis shows that simple exercise, individually tailored to each patient's preference and lifestyle, can help improve lung function and overall fitness.

4 May 2011

Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis

Has a bone density scan placed you at risk for osteoporosis, leading your doctor to prescribe a widely advertised bone-building medication? Not so fast! A University of Illinois study finds that an effective first course of action is increasing dietary calcium and vitamin D or taking calcium and vitamin D supplements.

3 May 2011

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

Santarus, Inc. today announced that the budesonide MMX Phase III clinical program will be featured in two oral presentations at the Digestive Disease Week Meeting being held at McCormick Place in Chicago on May 7-10, 2011.

3 May 2011

Belly fat predicts heart-disease risk better than BMI: Study

According to the latest study the fat around the belly is the chief culprit in the link between obesity and cardiovascular disease. This study raises the possibility that people can be overweight without significantly raising their heart risk, so long as they carry the extra fat in places other than their belly. In fact, a few extra pounds may even lower the risk of death from heart disease, researchers found.

3 May 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

3 May 2011

Omnicell first quarter revenue is $57.2 million for 2011

Omnicell, Inc., a leading global provider of system solutions to acute healthcare facilities, today announced results for its first quarter ended March 31, 2011.

From Omnicell, Inc. 3 May 2011

Exercise News and Research

Latest Exercise News and Research

Statins for all over 55: Study

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Boston Business Journal honors Tufts Health Plan for Worksite Wellness program

ZIOPHARM reports net loss of $39.0 million for first quarter 2011

Columbia Laboratories net revenues increase 74% to $12.5 million

AARP launches campaign to preserve health and retirement security of older Americans

Leukotriene antagonists can serve as effective alternative to conventional asthma treatment

Physical exercise generates nitric oxide intermediates critical for cardioprotection

Cardiac Dimensions initiates two CARILLON device trials in Functional Mitral Regurgitation

New online tool can help evaluate and improve emergency communications

Structured exercise training can reduce HbA1c levels in patients with diabetes

AHF cautions against fast track FDA-approval for expanded use of Gilead’s Truvada

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

Thoratec reports $99.5 million revenue for first quarter 2011

Exercise linked to improved lung status in children with cystic fibrosis

Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

Belly fat predicts heart-disease risk better than BMI: Study

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Omnicell first quarter revenue is $57.2 million for 2011

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Exercise News and Research

Latest Exercise News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in